BHICOTCServices-Computer Processing & Data PreparationFiscal year ends December 31

BioScience Health Innovations, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026

$6.78+0.00 (0.00%)

Close on Oct 16, 2026

Community

Notes and questions about BioScience Health Innovations from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in BioScience Health Innovations's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-4 reverse split on Oct 27, 2025
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is BHIC.

Revenue growth7.8% · median 352.3%

Gross margin53.8% · median 60.0%

Operating margin-13.7% · median -57.2%

Net margin-14.7% · median -89.8%

Advertisement
300 × 250